Skip to main content
. 2007 Apr 9;51(6):2016–2027. doi: 10.1128/AAC.01426-06

TABLE 1.

Summary of anti-HCV activities of various nutrients

Nutrient type Nutrient(s) with the indicated characteristic for HCVa
Inhibitory Enhancing Ineffective
Vitamins
    Liposoluble BC, VD2 VA (retinol), VE, VK1, VK2, VK3 VD3
    Water soluble VC VB1, VB2, VB3 (niacin), VB6, VB12, pantothenic acid, biotin, folic acid, inositol
Amino acids
    Branched-chain Leucine, isoleucine, valine
    Aromatic Tryptophan Phenylalanine, tyrosine
Fatty acids
    Saturated Lauric acid (C12), palmitic acid (C16), stearic acid (C18), behenic acid (C22)
    Mono-unsaturated Oleic acid (C18; 9-unsaturated), elaidic acid (C18; trans-form of oleic acid), vaccenic acid (C18; 11-unsaturated)
    Polyunsaturated LA (C18:2, n-6), AA (C20:4, n-6), EPA (C20:5, n-3), DHA (C22:6, n-3)
Salts Fe(II)SO4, Fe(III)(NO3)3, ZnCl2 Na2SeO4 NaCl, KCl, CaCl2, PCl3, MgCl2, CuCl2, MnCl2
a

Nutrients already contained in the medium are indicated in italics. VB1, vitamin B1; VB2, vitamin B2; VB3, vitamin B3; VB6, vitamin B6; VB12, vitamin B12; VK3, vitamin K3.